Showing results (81-90 of 194) with videos related to
Sort By:
Pageof 20
American Journal of Clinical Oncology|June 23, 2017
Predictors of Local Recurrence in Patients With MyxofibrosarcomaBismarck Odei, Jean-Claude Rwigema, Frederick R Eilber, et al.Oncotarget|September 3, 2016
Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytesElizabeth Shurell, Arun S Singh, Joseph G Crompton, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2024
Hypotensive drugs mitigate the high-sodium diet-induced pro-inflammatory activation of mouse macrophages in vivoMartyna Cieślik, Spencer D Strobel, Paweł Bryniarski, et al.Frontiers in Bioengineering and Biotechnology|March 11, 2020
Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and ActivationNanxia Zhao, Xue Yang, Hannah R Calvelli, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database AnalysisDanielle S Graham, Mykola Onyshchenko, Mark A Eckardt, et al.The Patient|May 31, 2020
Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical TrialJérémy Lambert, Alexia Marrel, Sandra P D'Angelo, et al.Plos One|September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanomaBegoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.Oncotarget|October 1, 2016
Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse modelKei Kawaguchi, Takashi Murakami, Bartosz Chmielowski, et al.JAMA Oncology|March 23, 2018
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical TrialSandra P D'Angelo, Jeffery Russell, Céleste Lebbé, et al.European Journal of Cancer (Oxford, England : 1990)|September 15, 2015
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumabZeynep Eroglu, Dae Won Kim, Xiaoyan Wang, et al.Pageof 20